+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sugar-Based Excipients Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4987126
  • Report
  • February 2020
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Ashland Inc.
  • Cargill, Inc.
  • Colorcon Inc.
  • DFE Pharma
  • Meggle AG
  • Roquette Group
  • MORE
The sugar-based excipients market studied was projected to grow with a CAGR of nearly 4.6% over the forecast period. The major factor attributing to the growth of the market are increasing use of co-processed excipients, rapid growth of the generic market as many of the key drugs’ patents are expired or on the verge of expiring. Furthermore, the growing preference of orally disintegrating tablets and thier development is boosting the market. Orally disintegrating tablets differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. As the number geriatric population and pediatric patients is increasing the demand for orally disintegrating tablets is increasing. However stringent regulatory rules that lead to a deficiency of FDA-approved products are liable to decrease the market growth to a certain extent.

Key Market Trends

The Actual Sugars Accounted For The Largest Share Of The Market
  • Sugar-based excipients have perceived broad recognition as ingredients in pharmaceutical tableting. They can be used to conceal the bitter taste of active agents thereby making it more palatable. As direct compression has become the preferred method of tablet manufacture, the demand has increased for compressible sugar-based excipients.
  • The major factors increasing the market growth of the segment are increasing pediatric patient pool, the actual sugars are used mainly in oral formulations due to its non-toxicity and negligible reaction with drugs. Furthermore, the rapid growth of generics market is boosting the growth of the segment.
Europe Dominates the Market and Expected to do Same in the Forecast Period

Europe is expected to dominate the overall sugar-based excipients market, throughout the forecast period. The largest share is mainly due to presence of major pharmaceutical companies and their usage of advanced medical technologies to develop better therapeutics. Sugar based excipient are the most common form of excipient used in oral medication. It is especially considered for medicines directed to children. It is widely used in sucrose, glycerol, saccharin sodium, sorbitol and others. Majorly in antibiotics and cough syrups for children. Furthermore, growing geriatric and pediatric patient pool also increases the market growth in this region. Increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region are the other factors responsible for the market growth.

Competitive Landscape

The Sugar-Based Excipients market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are DFE Pharma, Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation, Associated British Foods PLC, Cargill, Inc., Colorcon Inc., FMC Corporation, Meggle AG.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ashland Inc.
  • Cargill, Inc.
  • Colorcon Inc.
  • DFE Pharma
  • Meggle AG
  • Roquette Group
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Use of Co-processed Excipients
4.2.2 Rapid Growth in the Generics Market
4.2.3 Increasing Development of Orally Disintegrating Tablets
4.3 Market Restraints
4.3.1 Stringent Regulatory Requirements
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product
5.1.1 Actual sugar
5.1.2 Sugar alcohols
5.1.3 Artificial sweeteners
5.2 By Type
5.2.1 Powders/Granules
5.2.2 Direct compression sugars
5.2.3 Crystals
5.2.4 Others
5.3 By Application
5.3.1 Fillers and Diluents
5.3.2 Flavoring agents
5.3.3 Tonicity agents
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
6.1.1 DFE Pharma
6.1.2 Archer Daniels Midland Company
6.1.3 Ashland Inc.
6.1.4 Roquette Group
6.1.5 The Lubrizol Corporation
6.1.6 Associated British Foods PLC
6.1.7 Cargill, Inc.
6.1.8 Colorcon Inc.
6.1.9 Meggle AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • DFE Pharma
  • Archer Daniels Midland Company
  • Ashland Inc.
  • Roquette Group
  • The Lubrizol Corporation
  • Associated British Foods PLC
  • Cargill, Inc.
  • Colorcon Inc.
  • Meggle AG
Note: Product cover images may vary from those shown
Adroll
adroll